Welcome to LookChem.com Sign In|Join Free
  • or
2-Bromo-1,5-naphthyridine is a chemical compound characterized by the molecular formula C8H5BrN2. It is a brominated derivative of naphthyridine, a heterocyclic compound with potential applications in the synthesis of pharmaceuticals and agrochemicals. 2-Bromo-1,5-naphthyridine is recognized for its versatility in organic chemistry, particularly in the formation of heterocyclic compounds, and is valued for its reactivity in various chemical reactions such as nucleophilic substitution and transition metal-catalyzed cross-coupling reactions. Its utility extends to serving as a synthetic intermediate for the development of new therapeutic agents and other functional molecules.

51532-07-1

Post Buying Request

51532-07-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51532-07-1 Usage

Uses

Used in Pharmaceutical Synthesis:
2-Bromo-1,5-naphthyridine is utilized as a building block in the pharmaceutical industry for the synthesis of new therapeutic agents. Its chemical properties allow it to be a key component in the creation of diverse medicinal compounds, contributing to the development of novel treatments for various diseases and conditions.
Used in Agrochemical Development:
In the agrochemical sector, 2-Bromo-1,5-naphthyridine is employed as a precursor in the synthesis of new agrochemicals. Its ability to form heterocyclic compounds makes it a valuable intermediate for the production of pesticides, herbicides, and other agricultural chemicals that are designed to improve crop yields and protect plants from pests and diseases.
Used in Organic Chemistry Research:
2-Bromo-1,5-naphthyridine is also used as a research tool in organic chemistry. Its reactivity in nucleophilic substitution and transition metal-catalyzed cross-coupling reactions makes it an important compound for studying reaction mechanisms and developing new synthetic methodologies in the field of organic synthesis.
Used in the Synthesis of Heterocyclic Compounds:
2-Bromo-1,5-naphthyridine is applied as a synthetic intermediate for the formation of heterocyclic compounds, which are essential in various chemical and pharmaceutical applications. Its structural features facilitate the creation of complex heterocyclic systems that can exhibit unique chemical and biological properties.

Check Digit Verification of cas no

The CAS Registry Mumber 51532-07-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,5,3 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 51532-07:
(7*5)+(6*1)+(5*5)+(4*3)+(3*2)+(2*0)+(1*7)=91
91 % 10 = 1
So 51532-07-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrN2/c9-8-4-3-6-7(11-8)2-1-5-10-6/h1-5H

51532-07-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromo[1,5]naphthyridine

1.2 Other means of identification

Product number -
Other names 2-bromo-1,5-naphthyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51532-07-1 SDS

51532-07-1Downstream Products

51532-07-1Relevant academic research and scientific papers

SUBSTITUTED 1,5-NAPHTHYRIDINES OR QUINOLINES AS ALK5 INHIBITORS

-

Paragraph 226; 254; 266, (2021/05/29)

The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.

ALK5 INHIBITORS

-

Paragraph 0479; 0644; 0645, (2020/07/07)

The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 51532-07-1